CLSA upgrades iQIYI stock rating to Outperform on regulatory outlook

CLSA has upgraded iQIYI (NASDAQ:IQ) to Outperform and raised its price target to $2.45, primarily driven by the removal of a 20% valuation discount on expectations of regulatory relaxation in China. While CLSA forecasts an 11% year-over-year revenue decline and significant pressure on Q2 2025 operating profit to 80 million yuan, the firm maintains its 2025 adjusted operating profit forecast of 1.08 billion yuan, anticipating sequential improvement. The stock has seen strong momentum with a 25.95% return over the past week, indicating growing investor confidence despite the mixed near-term outlook and previously varied analyst sentiment.

Analysis

CLSA's upgrade of iQIYI (IQ) to Outperform with a new $2.45 price target is not driven by immediate fundamental strength, but rather by the removal of a 20% valuation discount based on potential regulatory easing in China. This forward-looking catalyst contrasts sharply with a challenging near-term outlook for the second quarter of 2025, for which CLSA forecasts an 11% year-over-year revenue decline to 6.6 billion yuan and a significant drop in adjusted operating profit to 80 million yuan from 501 million yuan a year prior. Gross profit margin is also expected to compress to 20.6%, pressured by flat content costs against falling revenue. The company's liquidity position appears tight, as indicated by a current ratio of 0.46. Despite these headwinds, CLSA maintains its full-year 2025 adjusted operating profit forecast of 1.08 billion yuan, anticipating a sequential recovery driven by upcoming content releases. This outlook is reflected in the stock's recent momentum, with a 25.95% return over the past week, suggesting investor sentiment is beginning to price in a second-half recovery and a more favorable regulatory environment, even as analyst ratings from firms like Citi and Benchmark remain mixed.

Key Decisions for Investors

• Investors should recognize that the recent stock appreciation is primarily fueled by a narrative of potential regulatory relief, not by current operational performance, which is expected to be weak in the upcoming quarter.
• Given the forecasted 11% year-over-year revenue decline, significant margin pressure, and a tight liquidity position indicated by a 0.46 current ratio, a cautious approach is warranted until tangible signs of a fundamental turnaround emerge.
• Monitor the Q2 2025 earnings report on August 20 closely for any validation of management's guidance and CLSA's expectation for a strong second-half recovery, as this is the key support for the current valuation re-rating.
• Consider the divergence in analyst ratings as a sign of uncertainty, with the bull case hinging on future content success and regulatory shifts, while the bear case focuses on near-term financial deterioration.